Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

Pernix, SEEK prep new cough med; FDA warns Quadex over herpes reference; NuMe progresses on prebiotic program; Creative Edge Nutrition expands; Reaction Nutrition records lacking; more news In Brief.

You may also be interested in...



In Brief

AHPA, GMP request registration renewal guidance; NAD defines ‘natural’ within industry, consumer expectations; Creative Edge Nutrition acquires supplement brands, A-Z-Nutrition; FDA warns EyeScience about drug claims; BioLogic loses NAD appeal; Estee Lauder anti-aging brand appeals NAD decision.

In Brief

POM, agency grilled during appeal to FTC board; Swander buys Physicians Formula; FDA again warns about Reumofan; Parrillo warned on GMPs, response; Potential botulism prompts Protica recalls; more news In Brief.

People In Brief

Morris joins CHPA federal affairs team; Fuson moves from FDA to consulting firm; Creative Edge Nutrition adds VP; former EPA executive joins Procter & Gamble sustainability panel; USANA strengthens scientist roster; more People In Brief.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS105764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel